Categories

Tags

AASLD

AASLD Plenary Session: Presidential Plenary
Date
May 22, 2022
SELADELPAR TREATMENT OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) FOR 2 YEARS IMPROVES THE GLOBE PBC SCORE AND PREDICTS IMPROVED TRANSPLANT-FREE SURVIVAL
Date
May 22, 2022
Speaker
Bettina Hansen
RNA N6-METHYLADENOSINE METHYLTRANSFERASE METTL3 DRIVES NAFLD-HCC THROUGH SUPPRESSING ANTITUMOR IMMUNITY
Date
May 22, 2022
Speaker
Yasi Pan
HIGHER PREVALENCE OF CARDIOVASCULAR DISEASE AMONG LEAN VERSUS NON-LEAN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE DESPITE LOWER PREVALENCE OF ATHEROGENIC RISK AND METABOLIC DISEASES
Date
May 22, 2022
Speaker
Karn Wijarnpreecha
SPATIAL TRANSCRIPTOMIC CHARACTERIZATION OF HEPATOCELLULAR CARCINOMA (HCC) REVEALS PREDICTIVE BIOMARKERS AND MOLECULAR TARGETS OF RECURRENCE
Date
May 22, 2022
Speaker
Akanksha Suresh
SINGLE NUCLEUS RNA SEQUENCING IDENTIFIED THE ASSOCIATION OF SPHINGOLIPID METABOLISM DYSREGULATION WITH IMMUNE CELL INFILTRATION AND CHOLANGIOCYTE SENESCENCE IN MDR2-/- MICE.
Date
May 22, 2022
Speaker
Kaitlyn Jackson
REAL-WORLD TREATMENT OUTCOME WITH PROTEASE INHIBITOR (PI) VS NON-PI DIRECT ACTING ANTIVIRALS (DAAS) IN DECOMPENSATED HCV CIRRHOSIS: A REAL-C STUDY
Date
May 22, 2022
Speaker
Yu Wong
AASLD State-of-the-Art Lecture: Emerging Therapies in NASH: Current Challenges and Potential Opportunities
Date
May 22, 2022
EMERGING THERAPIES IN NASH: CURRENT CHALLENGES AND POTENTIAL OPPORTUNITIES
Date
May 22, 2022
Speaker
Manal Abdelmalek
AASLD State-of-the-Art Lecture: Hepatitis B - The Road to Elimination from Discovery to Treatment and Cure
Date
May 22, 2022
HEPATITIS B - THE ROAD TO ELIMINATION FROM DISCOVERY TO TREATMENT AND CURE
Date
May 22, 2022
Speaker
Harry Janssen
AASLD Conference/Debate/Panel/Symposium: Academic Debates
Date
May 22, 2022
UPDATE ON THE MEDICAL TREATMENT OF ALCOHOL-ASSOCIATED HEPATITIS
Date
May 22, 2022
Speaker
Gene Im
UPDATE ON LIVER TRANSPLANTATION FOR ALCOHOL-ASSOCIATED HEPATITIS
Date
May 22, 2022
Speaker
Pratima Sharma
DEBATE: "INPATIENT WITH ALCOHOL-ASSOCIATED HEPATITIS WHO IS NOT CURRENTLY A LIVER TRANSPLANT CANDIDATE, SHOULD RENAL REPLACEMENT THERAPY BE OFFERED?"
Date
May 22, 2022
Speaker
Gene Im
AASLD State-of-the-Art Lecture: Impact from Alcohol Use Disorder in the United States: Going Forward After the Pandemic
Date
May 23, 2022
IMPACT FROM ALCOLHOL USE DISORDER IN THE UNITED STATES, GOING FORWARD AFTER THE PANDEMIC
Date
May 23, 2022
Speaker
Jessica Mellinger
AASLD Address/Oration/Lecture: Practice Guidelines Workshop: A Summary of New Recommendations for Noninvasive Liver Disease Assessment Guideline, and Guidances on Malnutrition, Sarcopenia & Frailty, Primary Sclerosing Cholangitis-Cholangiocarcinoma, a
Date
May 23, 2022
Introduction
Date
May 23, 2022
NONINVASIVE LIVER DISEASE ASSESSMENT
Date
May 23, 2022
Speaker
Andres Rojo
AASLD GUIDANCE ON MALNUTRITION, SARCOPENIA AND FRAILTY
Date
May 23, 2022
Speaker
Jennifer Lai
PRIMARY SCLEROSING CHOLANGITIS CHOLANGIOCARCINOMA
Date
May 23, 2022
Speaker
David Assis
PALLIATIVE CARE AND END-STAGE LIVER DISEASE
Date
May 23, 2022
Speaker
Shari Rogal
Closing Remarks
Date
May 23, 2022